retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Agonism Based Therapies for | Current Cardiovascular Risk Reports Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31





















